APLN and diabetic kidney disease: Apelin is a novel endogenous peptide recently recognized as a therapeutic target for glucose homeostasis and diabetic complications [32, 63], and TGF-β is a pleiotropic cytokine associated with progressive diabetic nephropathy and liver injury [11].